Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon

M. Lisker-Melman, D. Webb, A. M. Di Bisceglie, C. Kassianides, P. Martin, V. Rustgi, J. G. Waggoner, Y. Park, J. H. Hoofnagle

Research output: Contribution to journalArticle

85 Scopus citations

Abstract

A high proportion of patients with HBV-related glomerulonephritis will respond to a 4-month course of alpha-interferon with a clinical, biochemical, and serologic remission.

Original languageEnglish (US)
Pages (from-to)479-483
Number of pages5
JournalAnnals of internal medicine
Volume111
Issue number6
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint Dive into the research topics of 'Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon'. Together they form a unique fingerprint.

  • Cite this

    Lisker-Melman, M., Webb, D., Di Bisceglie, A. M., Kassianides, C., Martin, P., Rustgi, V., Waggoner, J. G., Park, Y., & Hoofnagle, J. H. (1989). Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon. Annals of internal medicine, 111(6), 479-483. https://doi.org/10.7326/0003-4819-111-6-479